Status:
COMPLETED
Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Palo Alto Medical Foundation
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Healthy Men Age 50 Who Are Considering PSA Screening
Eligibility:
MALE
50-75 years
Phase:
NA
Brief Summary
In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and ...
Detailed Description
We will use a randomized experimental design to compare the effects of 3 different strategies to implement a prostate cancer screening decision support intervention (DESI) with a control condition in ...
Eligibility Criteria
Inclusion
- age 50 or older
- do not have a prostate diagnosis
- have not had a PSA test in the past 10 months
- have not seen their primary care physicians in the last 3 months
Exclusion
- Women
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
2521 Patients enrolled
Trial Details
Trial ID
NCT01241656
Start Date
January 1 2011
End Date
December 1 2012
Last Update
June 25 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States, 94301
2
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States, 27599